Omkar Pharmachem Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported revenue was INR 1.35 million compared to INR 0.45 million a year ago. Net income was INR 0.812 million compared to net loss of INR 0.206 million a year ago. Basic earnings per share from continuing operations was INR 0.0805 compared to basic loss per share from continuing operations of INR 0.0204 a year ago.
For the nine months, revenue was INR 4.05 million compared to INR 1.35 million a year ago. Net income was INR 1.82 million compared to net loss of INR 0.627 million a year ago. Basic earnings per share from continuing operations was INR 0.1807 compared to basic loss per share from continuing operations of INR 0.0622 a year ago.